|
|
CD85j (ILT2) Antibody, anti-human, PE-Vio 615, REAfinity 130-116-739 |
FCM
IF
IHC
Other
MC
|
Hu
|
PE-Vio 615
|
REA998 |
30 テスト(60 µL) |
¥28,600 |
|
|
|
CD85j (ILT2) Antibody, anti-human, PE-Vio 615, REAfinity 130-116-618 |
FCM
IF
IHC
Other
MC
|
Hu
|
PE-Vio 615
|
REA998 |
100 テスト(200 µL) |
¥65,700 |
|
|
|
CD32 Antibody, anti-human, PE-Vio 615, REAfinity 130-116-728 |
FCM
IF
IHC
Other
MC
|
Hu
NHPr
|
PE-Vio 615
|
REA997 |
30 テスト(60 µL) |
¥28,600 |
|
|
|
CD32 Antibody, anti-human, PE-Vio 615, REAfinity 130-116-607 |
FCM
IF
IHC
Other
MC
|
Hu
NHPr
|
PE-Vio 615
|
REA997 |
100 テスト(200 µL) |
¥65,700 |
|
|
|
CD273 (PD-L2) Antibody, anti-human, PE-Vio 615, REAfinity 130-116-570 |
FCM
IF
IHC
Other
MC
|
Hu
|
PE-Vio 615
|
REA985 |
100 テスト(200 µL) |
¥65,700 |
|
|
|
CD273 (PD-L2) Antibody, anti-human, PE-Vio 615, REAfinity 130-116-691 |
FCM
IF
IHC
Other
MC
|
Hu
|
PE-Vio 615
|
REA985 |
30 テスト(60 µL) |
¥28,600 |
|
|
|
CD64 Antibody, anti-human, PE-Vio 615, REAfinity 130-116-204 |
FCM
IF
IHC
Other
MC
|
Hu
NHPr
|
PE-Vio 615
|
REA978 |
100 テスト(200 µL) |
¥65,700 |
|
|
|
CD64 Antibody, anti-human, PE-Vio 615, REAfinity 130-116-307 |
FCM
IF
IHC
Other
MC
|
Hu
NHPr
|
PE-Vio 615
|
REA978 |
30 テスト(60 µL) |
¥28,600 |
|
|
|
CD2 Antibody, anti-human, PE-Vio 615, REAfinity 130-116-157 |
FCM
IF
IHC
Other
MC
|
Hu
NHPr
|
PE-Vio 615
|
REA972 |
100 テスト(200 µL) |
¥65,700 |
|
|
|
CD2 Antibody, anti-human, PE-Vio 615, REAfinity 130-116-260 |
FCM
IF
IHC
Other
MC
|
Hu
NHPr
|
PE-Vio 615
|
REA972 |
30 テスト(60 µL) |
¥28,600 |
|
|
|
CD158e/k (KIR3DL1/DL2) Antibody, anti-human, PE-Vio 615, REAfinity 130-116-183 |
FCM
MC
|
Hu
|
PE-Vio 615
|
REA970 |
100 テスト(200 µL) |
¥65,700 |
|
|
|
CD158e/k (KIR3DL1/DL2) Antibody, anti-human, PE-Vio 615, REAfinity 130-116-286 |
FCM
MC
|
Hu
|
PE-Vio 615
|
REA970 |
30 テスト(60 µL) |
¥28,600 |
|
|
|
CD86 Antibody, anti-human, PE-Vio 615, REAfinity 130-116-270 |
FCM
MC
|
Hu
|
PE-Vio 615
|
REA968 |
30 テスト(60 µL) |
¥28,600 |
|
|
|
CD86 Antibody, anti-human, PE-Vio 615, REAfinity 130-116-167 |
FCM
MC
|
Hu
|
PE-Vio 615
|
REA968 |
100 テスト(200 µL) |
¥65,700 |
|
|
|
CD181 (CXCR1) Antibody, anti-human, PE-Vio 615, REAfinity 130-115-956 |
FCM
IF
IHC
Other
MC
|
Hu
|
PE-Vio 615
|
REA958 |
30 テスト(60 µL) |
¥28,600 |
|
|
|
CD181 (CXCR1) Antibody, anti-human, PE-Vio 615, REAfinity 130-115-887 |
FCM
IF
IHC
Other
MC
|
Hu
|
PE-Vio 615
|
REA958 |
100 テスト(200 µL) |
¥65,700 |
|
|
|
CD158f (KIR2DL5) Antibody, anti-human, PE-Vio 615, REAfinity 130-115-844 |
FCM
MC
|
Hu
|
PE-Vio 615
|
REA955 |
100 テスト(200 µL) |
¥65,700 |
|
|
|
CD158f (KIR2DL5) Antibody, anti-human, PE-Vio 615, REAfinity 130-115-916 |
FCM
MC
|
Hu
|
PE-Vio 615
|
REA955 |
30 テスト(60 µL) |
¥28,600 |
|
|
|
CD21 Antibody, anti-human, PE-Vio 615, REAfinity 130-115-519 |
FCM
MC
|
Hu
|
PE-Vio 615
|
REA940 |
100 テスト(200 µL) |
¥65,700 |
|
|
|
CD21 Antibody, anti-human, PE-Vio 615, REAfinity 130-115-613 |
FCM
MC
|
Hu
|
PE-Vio 615
|
REA940 |
30 テスト(60 µL) |
¥28,600 |
|